New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
07:49 EDTKNDKindred Healthcare volatility low into cutting 2013 outlook
Kindred Healthcare overall option implied volatility of 41 is below its 26-week average of 49 according to Track Data, suggesting decreasing price movement into lowering its FY13 EPS view due to fiscal cliff legislation.
News For KND From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
17:23 EDTKNDKindred Healthcare reports 14.6% stake in Gentiva Health
Subscribe for More Information
October 10, 2014
16:19 EDTKNDNorth Tide reports 5.72% passive stake in Kindred Healthcare
Subscribe for More Information
11:17 EDTKNDKindred Healthcare upgraded to Outperform at Avondale (pre-open)
Pre-open, Avondale upgraded Kindred Healthcare (KND) to Outperform from Market Perform (KND) citing the company's agreement to purchase Gentiva (GTIV).
10:01 EDTKNDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:30 EDTKNDKindred Healthcare upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
October 9, 2014
16:25 EDTKNDOn The Fly: Closing Wrap
Subscribe for More Information
12:30 EDTKNDOn The Fly: Midday Wrap
Subscribe for More Information
10:41 EDTKNDHigh option volume stocks
Subscribe for More Information
09:35 EDTKNDKindred Healthcare sees Gentiva deal closing in 1Q15
Subscribe for More Information
08:46 EDTKNDKindred sees 'significant,' 'achievable' synergies from Gentiva deal
Kindred (KND) says it expects to issue in aggregate $620M-$720M of equity to maintain reasonable leverage. Says will issue Gentiva (GTIV) shareholders $200M in Kindred stock as part of purchase consideration, plans to raise $200M-$300M in equity and/or mandatory convertible securities between announcement and close. Says integration teams assembled, ready to be deployed immediately upon closing. Comments from slides that will be presented on Kindred's conference call discussing the proposed acquisition of Gentiva.
08:45 EDTKNDGentiva volatility low into being acquired by Kindred for $1.8B
Subscribe for More Information
08:38 EDTKNDKindred volatility flat into acquiring Gentiva for $1.8B
Subscribe for More Information
08:27 EDTKNDKindred sees Gentiva deal immediately and significantly accretive
Kindred (KND) expects the acquisition of Gentiva (GTIV) will be immediately and significantly accretive to earnings and operating cash flows, exclusive of transaction and integration costs. Kindred expects the acquisition to be approximately 40c-60c accretive to pro forma earnings, and pro forma operating cash flows of $350 million to $400 million, both on a run rate basis, once Gentiva is fully integrated and expected synergies are fully realized in the second full year following the closing. On this same basis, following the combined company’s expected annual maintenance capital expenditures of $120 million to $130 million, Kindred expects pro forma cash flows of $230 million to $270 million. Kindred has identified approximately $70 million of annual cost and operating synergies and expects to achieve the full run rate within two years of closing, of which approximately $35 million is expected to be achieved in the first year following the closing. Kindred expects the majority of cost synergies to be achieved through combining information technology functions, merging supply chains and eliminating redundant public company expenses. In addition, Kindred expects to realize revenue synergies that will improve patient care transitions and choice, and drive volume growth as a result of cross-selling across the combined service platform. Kindred expects annual run rate revenue synergies of more than $60 million over time, with approximately $20 million to $30 million achievable in the first full year following the closing.
08:26 EDTKNDKindred Healthcare says combined company to operate in 47 states
Subscribe for More Information
08:25 EDTKNDKindred to acquire Gentiva for $19.50 per share in cash and stock, or $1.8B
Kindred Healthcare (KND) and Gentiva Health Services (GTIV) announced that the companies have entered into a definitive merger agreement under which Kindred will acquire all of the outstanding shares of Gentiva common stock for $19.50 per share in a combination of cash and stock. The agreement was unanimously approved by the boards of directors of both companies. Under the terms of the agreement, Gentiva shareholders will receive $14.50 per share in cash and $5.00 of Kindred common stock. The transaction is valued at $1.8 billion, including the assumption of net debt. The companies expect the closing of the transaction to occur in the first quarter of 2015. The combined company will: Employ approximately 109,000 individuals, making it the 78th largest private employer and the 4th largest healthcare employer in the United States; Deliver pro forma annual revenues of approximately $7.1 billion; and Generate pro forma operating income, including expected cost synergies, of $1.0 billion. Paul J. Diaz, CEO of Kindred, said, “Over the last eight weeks, we undertook a robust due diligence process and worked closely and constructively with our counterparts at Gentiva to better understand their operations, financial results and outlook. This process confirmed the compelling strategic rationale and industrial logic of this combination, as well as our belief that this transaction is in the best interests of both companies and our respective shareholders, patients, employees and business partners." Kindred has obtained committed financing from Citi and J.P. Morgan in connection with the pending transaction. Subject to market and other conditions, the Company expects to finance the acquisition of Gentiva and associated costs through the issuance of $200 million to $300 million of common stock and mandatory convertible equity securities and $1.3 billion to $1.4 billion of unsecured notes prior to the closing of the acquisition. The Company expects to fund the remaining amounts through its existing line of credit. Following completion of the transaction, Kindred expects to have approximately 85 million fully diluted shares outstanding, comprised primarily of approximately 64 million shares outstanding today, approximately 10 million shares to be issued to Gentiva as part of the transaction consideration, and approximately nine million to 12 million shares associated with the expected offering of common stock and mandatory convertible equity securities. The Gentiva acquisition is subject to certain conditions, including the approval by the stockholders of Gentiva. Kindred and Gentiva have already received clearance for the transaction under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
08:23 EDTKNDKindred to acquire Gentiva for $19.50 per share in cash and stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use